Abstract
Racial disparities impacting management of psoriasis patients are incompletely understood. The objective of this study was to assess biologic discontinuation and switching rates after 6-months of therapy among psoriasis patients of different racial/ethnic backgrounds in the US/Canadian CorEvitas Psoriasis Registry. This study included patients who initiated a biologic between April 2015-March 2021 and had a known treatment status at 6-months follow-up. Patient characteristics at initiation were compared by race/ethnicity.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call